Back to Archived News
Nixon Peabody LLP Expands Its Life Sciences Practice
Wednesday, August 01, 2007
Experienced Patent Attorney, Jill Uhl, Joins the Firm from EMD Serono, Inc.
Boston, MA -- Nixon Peabody LLP announces the expansion of its life sciences and technology and intellectual property practices with the addition of Jill Uhl as counsel. Ms. Uhl focuses her practice on all aspects of biotech and pharmaceutical patent prosecution, business transactions, client counseling, and litigation.
Prior to joining Nixon Peabody, Ms. Uhl was U.S. patent counsel for EMD Serono, Inc., where she managed U.S. and foreign litigation and the U.S. intellectual property department, as well as drafting and negotiating collaboration, licensing, and strategic alliance agreements. She also has extensive experience in all aspects of biotech and biochemical prosecution and litigation.
Susan Robfogel, leader of Nixon Peabody’s life sciences practice said, "We’re excited to welcome Jill to Nixon Peabody. Jill’s background is a strong asset to the firm as she has extensive knowledge and insight into intellectual property issues specifically facing the life sciences community."
Andrew Glincher, managing partner of Nixon Peabody’s Boston office, added, "Jill’s arrival strengthens our intellectual property and life sciences presence in Boston and beyond. Her knowledge of patent issues in life sciences arena is especially valuable to our biotech clients."
Ms. Uhl is a member of the American Intellectual Property Law Association and the Boston Patent Law Association and is active in several industry organizations, including BIO and PhRMA. Ms. Uhl graduated from University of Kentucky and earned her J.D. degree from University of Cincinnati.
About Nixon Peabody’s Technology and Intellectual Property Group
Nixon Peabody ranks among the top patent, trademark, and intellectual property litigation firms in the U.S. Its 90-member team includes more than 50 registered patent attorneys, many of whom hold Ph.D.s or other advanced degrees. The team offers a blend of superior legal skills, engineering knowledge, and business judgment to assist clients in maximizing competitive advantages while minimizing risks. Clients include some of the country’s leading academic institutions and research centers, Nobel Prize winners, entrepreneurs, and Fortune 500 companies.
More than 100 attorneys and scientists comprise Nixon Peabody’s life sciences practice, working in close partnership with domestic and international clients to advance their strategic interests at every stage of the company life cycle. Clients include start-ups, established companies, and many of the nation’s most esteemed research institutions. Services include financing, incorporation, intellectual property protection, licensing, mergers and acquisitions and strategic alliances, FDA regulatory counsel, product marketing, and litigation. Nixon Peabody’s 17 office locations reflect the centers for life sciences research and commercialization in the United States, including in Boston, San Francisco, Los Angeles, Philadelphia, and Washington, DC.
About Nixon Peabody
Nixon Peabody LLP is one of the largest law firms in the United States. With 700 attorneys collaborating across 25 major practice areas in 17 office locations, including Boston, Chicago, Los Angeles, New York City, Rochester, San Francisco, Silicon Valley, and Washington, D.C., the firm’s size, diversity, and advanced technological resources enable it to offer comprehensive legal services to individuals and organizations of all sizes in local, state, national, and international matters. Nixon Peabody is one of only five law firms to be recognized by FORTUNE magazine as one of its "100 Best Companies To Work For®" in 2007 for the second consecutive year. The firm has also been a "Best Place to Work" by the Boston Business Journal in 2007. Additionally, the Human Rights Campaign Foundation recognized Nixon Peabody on its 2007 "Best Places To Work For GLBT Equality" list.
Back to Archived News